inclusion criteria: 1. men and woman age 30 and older; 2. not currently hospitalized 3. proven sars-cov-2 positive (per lab or physician report). 4. currently symptomatic with one or more of the following symptoms: fever, cough, myalgia, mild dyspnea, chest pain, diarrhea, nausea, vomiting, anosmia (inability to smell), ageusia (inability to taste), sore throat, nasal congestion. 5. able to provide informed consent. 6. upon initial screening, participant reports one of the following risk factors for clinical deterioration: age≥40, racial/ethnic group african-american, hispanic, or native american (including more than one race), or 1+ of the following medical conditions which increase risk for developing moderate-severe covid illness: obesity, hypertension, diabetes, heart disease (coronary artery disease, history of myocardial infarction, or heart failure), lung disease (eg asthma, copd), immune disorder (eg rheumatoid arthritis, lupus).

inclusion criteria: 1. men and woman age 30 and older; 2. not currently hospitalized 3. proven sars-cov-2 positive (per lab or physician report). 4. currently symptomatic with one or more of the following symptoms: fever, cough, myalgia, mild dyspnea, chest pain, diarrhea, nausea, vomiting, anosmia (inability to smell), ageusia (inability to taste), sore throat, nasal congestion. 5. able to provide informed consent. 6. upon initial screening, participant reports one of the following risk factors for clinical deterioration: age≥40, racial/ethnic group african-american, hispanic, or native american (including more than one race), or 1+ of the following medical conditions which increase risk for developing moderate-severe covid illness: obesity, hypertension, diabetes, heart disease (coronary artery disease, history of myocardial infarction, or heart failure), lung disease (eg asthma, copd), immune disorder (eg rheumatoid arthritis, lupus).

inclusion criteria: men and woman age 30 and older; not currently hospitalized proven sars-cov-2 positive (per lab or physician report). currently symptomatic with one or more of the following symptoms: fever, cough, myalgia, mild dyspnea, chest pain, diarrhea, nausea, vomiting, anosmia (inability to smell), ageusia (inability to taste), sore throat, nasal congestion. able to provide informed consent. upon initial screening, participant reports one of the following risk factors for clinical deterioration: age≥40, racial/ethnic group african-american, hispanic, or native american (including more than one race), or 1+ of the following medical conditions which increase risk for developing moderate-severe covid illness: obesity, hypertension, diabetes, heart disease (coronary artery disease, history of myocardial infarction, or heart failure), lung disease (eg asthma, copd), immune disorder (eg rheumatoid arthritis, lupus).

inclusion criteria: men and woman age 30 and older; not currently hospitalized proven sars-cov-2 positive (per lab or physician report). currently symptomatic with one or more of the following symptoms: fever, cough, myalgia, mild dyspnea, chest pain, diarrhea, nausea, vomiting, anosmia (inability to smell), ageusia (inability to taste), sore throat, nasal congestion. able to provide informed consent. upon initial screening, participant reports one of the following risk factors for clinical deterioration: age≥40, racial/ethnic group african-american, hispanic, or native american (including more than one race), or 1+ of the following medical conditions which increase risk for developing moderate-severe covid illness: obesity, hypertension, diabetes, heart disease (coronary artery disease, history of myocardial infarction, or heart failure), lung disease (eg asthma, copd), immune disorder (eg rheumatoid arthritis, lupus).

inclusion criteria: 1. men and woman age 30 and older; 2. not currently hospitalized 3. proven sars-cov-2 positive (per lab or physician report). 4. currently symptomatic with one or more of the following symptoms: fever, cough, myalgia, mild dyspnea, chest pain, diarrhea, nausea, vomiting, anosmia (inability to smell), ageusia (inability to taste), sore throat, nasal congestion. 5. able to provide informed consent. 6. upon initial screening, participant reports one of the following risk factors for clinical deterioration: age≥40, racial/ethnic group african-american, hispanic, or native american (including more than one race), or 1+ of the following medical conditions which increase risk for developing moderate-severe covid illness: obesity, hypertension, diabetes, heart disease (coronary artery disease, history of myocardial infarction, or heart failure), lung disease (eg asthma, copd), immune disorder (eg rheumatoid arthritis, lupus).

inclusion criteria: 1. men and woman age 30 and older; 2. not currently hospitalized 3. proven sars-cov-2 positive (per lab or physician report). 4. currently symptomatic with one or more of the following symptoms: fever, cough, myalgia, mild dyspnea, chest pain, diarrhea, nausea, vomiting, anosmia (inability to smell), ageusia (inability to taste), sore throat, nasal congestion. 5. able to provide informed consent. 6. upon initial screening, participant reports one of the following risk factors for clinical deterioration: age≥40, racial/ethnic group african-american, hispanic, or native american (including more than one race), or 1+ of the following medical conditions which increase risk for developing moderate-severe covid illness: obesity, hypertension, diabetes, heart disease (coronary artery disease, history of myocardial infarction, or heart failure), lung disease (eg asthma, copd), immune disorder (eg rheumatoid arthritis, lupus).

inclusion criteria: 1. men and woman age 18 and older; 2. not currently hospitalized 3. proven sars-cov-2 positive (per lab or physician report). 4. currently symptomatic with one or more of the following symptoms: fever, cough, myalgia, mild dyspnea, chest pain, diarrhea, nausea, vomiting, anosmia (inability to smell), ageusia (inability to taste), sore throat, nasal congestion. 5. able to provide informed consent. 6. upon initial screening, participant reports one of the following risk factors for clinical deterioration: age≥40, racial/ethnic group african-american, hispanic, or native american (including more than one race), or 1+ of the following medical conditions which increase risk for developing moderate-severe covid illness: obesity, hypertension, diabetes, heart disease (coronary artery disease, history of myocardial infarction, or heart failure), lung disease (eg asthma, copd), immune disorder (eg rheumatoid arthritis, lupus).

inclusion criteria: 1. men and woman age 18 and older; 2. not currently hospitalized 3. proven sars-cov-2 positive (per lab or physician report). 4. currently symptomatic with one or more of the following symptoms: fever, cough, myalgia, mild dyspnea, chest pain, diarrhea, nausea, vomiting, anosmia (inability to smell), ageusia (inability to taste), sore throat, nasal congestion. 5. able to provide informed consent. 6. upon initial screening, participant reports one of the following risk factors for clinical deterioration: age≥40, racial/ethnic group african-american, hispanic, or native american (including more than one race), or 1+ of the following medical conditions which increase risk for developing moderate-severe covid illness: obesity, hypertension, diabetes, heart disease (coronary artery disease, history of myocardial infarction, or heart failure), lung disease (eg asthma, copd), immune disorder (eg rheumatoid arthritis, lupus).